Market Research Logo

The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers)


Attention: There is an updated edition available for this report.

The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development.   This Kalorama Information report focuses on both the clinical biomarkers and research biomarkers in medicine.

Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease.  With them, diseases are detected earlier, more effective treatments can be delivered, drug reactions reduced.  An example is creatine kinase, or CK-MB, a marker that facilitates high-energy phosphates in the body’s tissues, and can suggest a cardiovascular event when levels are high.  Other markers can identify the seriousness of tumors or signal immune system problems.

These biomarkers are valuable in assessing risk, detecting current disorders or diseases, treatment assessments, drug matching, etc. In research, biomarkers are useful for drug development and determining new markers for drug targeting.

The report will provide a market analysis for five broad areas of medical biomarkers:

  • The Market for Cancer Biomarkers (by Type of Cancer)
  • The Market for Cardiovascular and Blood Biomarkers
  • The Market for Endocrine and Immune Biomarkers
  • The Market for Infectious Disease Biomarkers (by Disease)
  • The Market for Neurological Disease Biomarkers
For each area, additional market detail is provided:
  • Segment Breakouts
  • Regional Breakout (US, EMEA, Other)
  • Market Share
Market analysis in this report considers both the epidemiological considerations and the size patient groups, available biomarkers in each segment, and estimated percentage of biomarker use in patient treatment.
The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers. 

All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Market data pertains to the world market at the manufacturers’ level. The base year for data was 2013. Historical data was provided for the years 2008 through 2012, with forecast data provided for 2014 through 2018. Compound annual growth rates (CAGRs) are provided for the 2008-2013 and 2013-2018 periods for each segment covered.

Basic competitor summaries are included in each segment. The forecasted market analysis for 2014-2018 was largely based on demographic trends, new developments, biomarker development, company performance trends, merger and acquisitions, and global expansion.
Company profiles in this report include:
  • 20/20 GeneSystems
  • Abbott Laboratories
  • Affymetrix
  • Agendia
  • Alere
  • Beckman Coulter
  • Becton Dickinson
  • Biocartis SA
  • Biodesix
  • bioMerieux
  • BioReference Laboratory
  • bioTheranostics
  • CardioDX
  • Celera Alameda
  • Clarient
  • deCODE Genetics
  • DiaGenic
  • Genomic Health
  • Genoptix Medical Laboratory
  • Illumina
  • Johnson & Johnson
  • Life Techologies
  • Memory Dx
  • Myriad Genetics
  • Nanostring Technologies
  • OPKO Health
  • Provista Dx
  • Qiagen
  • Roche
  • Seimens Healthcare
  • Singulex
  • Tethys Bioscience
  • Thermo Fisher Scientific


  • Executive Summary
    • OVERVIEW
    • SCOPE AND METHODOLOGY
    • TOTAL SIZE AND GROWTH OF THE MARKET
      • Table The Global Medical Biomarker Market 2008-2018
    • ISSUES AND TRENDS AFFECTING MARKET
    • LEADING COMPETITORS
  • Introduction to the Medical Biomarkers Industry
    • OVERVIEW
      • Types of Biomarkers
    • HISTORY AND DEFINITION OF BIOMARKERS IN MEDICINE
    • PERSONALIZED MEDICINE
      • Potential Benefits
      • Privacy and Public Perception
    • BIOMARKERS AS RISK ASSESSMENT TOOL
    • BIOMARKERS AS DIAGNOSTIC TOOL
    • BIOMARKERS AS SCREENING TOOL
    • BIOMARKERS AS TREATMENT SELECTION TOOL
    • BIOMARKERS AS THERAPY MONITORING TOOL
    • TECHNOLOGIES
      • Table Differences Between DNA Biomarkers, DNA Tumor Biomarkers, and General Biomarkers
      • Table Selected Biomarkers in Current Use
      • DNA Biomarkers
      • DNA Tumor Biomarkers
      • General Biomarkers
  • Industry Trends
    • THE HEALTH INDUSTRY
      • Table Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2011
    • POPULATION DEMOGRAPHICS
      • Table Estimated World Population by Age and Geographical Region, 2012
      • Life Expectancy
        • Table Average Life Expectancy in Years by Country 1980 and 2012
      • Chronic Disease Impact
        • Table Selected Disease Statistics, Worldwide, as at July 2012
    • DISEASE AND ANAGING POPULATION
      • Table Elderly Support Ratio in Selected Countries (2050) (Note: Ratio is Number of 15 to 64 year olds for every 65+ year old.)
    • HEALTHCARE REFORM IN THE UNITED STATES
    • ANTIMICROBIAL DRUG RESISTANCE
    • BRIC INVOLVEMENT
      • Table Available Market Data, 2010
      • Table BRIC Healthcare Infrastructure Capacity
    • REGULATORY STRUCTURE
    • MOLECULAR TEST REIMBURSEMENT
  • Biomarkers in Cancer
    • OVERVIEW
      • Biochemistry of Cancer Cells
      • Carcinogen Metabolism
      • Causes of Cancer Growth
        • Table Viruses Associated with Cancer in Humans
    • HISTORY OF CANCER
    • CANCER TYPES
      • Table World Cancer Incidence by Selected Types of Cancer, 2010 and 2020, all races, both sexes
      • Table Total Cancer Incidence by Sex and Country, 2010 Estimates
    • BIOMARKER EXAMPLES
    • NEW DEVELOPMENTS
      • Table Selected Cancer Biomarkers in Development
    • TOTAL MARKET SIZE AND FORECAST
      • Table Global Cancer Biomarker Market 2008-2018
      • Cancer Biomarker Market by Geographical Region
    • COMPETITOR SUMMARY
  • Biomarkers in Cardiovascular Disease and Blood Disorders
    • OVERVIEW
    • THE CARDIOVASCULAR SYSTEM
      • Heart
      • Circulatory System
      • Cardiac Cycle
      • Coronary Circulation
      • Cardiac Myocytes
      • Molecular Contraction
    • CARDIOVASCULAR AND BLOOD DISEASES
      • Ischemic Heart Disease
      • Valvular and Endocardial Diseases
      • Pericardial Diseases
      • Myocardial Diseases
      • Congenital Heart Diseases
      • Congestive Heart Failure
      • Cardiac Dysrhythmias
      • Hypertension
      • Blood Disorders
      • Hyperlipidemia
    • BIOMARKER AVAILABILITY
    • NEW DEVELOPMENTS
      • Table Selected Cardiac Markers in Development
    • TOTAL MARKET SIZE AND FORECAST
      • Table Global Cardiovascular and Blood Disorder Biomarker Market 2008-2018
      • Cardiovascular Disease and Blood Disorder Biomarker Market by Geographical Region
    • COMPETITOR SUMMARY
  • Biomarkers in Endocrine and Immune Disorders
    • OVERVIEW
      • The Endocrine System
      • Immune System
    • DISEASE OVERVIEW
      • Classification of Endocrine Disorders
      • Growth Hormone Disorders
      • Antidiuretic Hormone Disorders
      • Thyroid Hormone Disorders
      • Diabetes Mellitus
    • BIOMARKER AVAILABILITY
    • NEW DEVELOPMENTS
      • Table Selected Endocrine, Autoimmune, Inflammatory and Other Markers in Development
    • TOTAL MARKET SIZE AND FORECAST
      • Table Global Endocrine and Immune Disorder Biomarker Market 2008-2018
      • Endocrine and Immune Disorder Biomarker Market by Geographical Region
    • COMPETITOR SUMMARY
  • Biomarkers in Infectious Disease
    • OVERVIEW
    • INFECTION
    • INFECTIOUS DISEASES
      • HIV Disease
      • Hepatitis C
      • Human Papillomavirus (HPV)
      • Sepsis
    • BIOMARKER AVAILABILITY
    • NEW DEVELOPMENTS
      • Table Selected Infectious Disease Markers in Development
    • TOTAL MARKET SIZE AND FORECAST
      • Table Global Infectious Disease Biomarker Market 2008-2018
      • Infectious Disease Biomarker Market by Geographical Region
    • COMPETITOR SUMMARY
  • Biomarkers in Nervous System Disorders
    • OVERVIEW
    • THE NERVOUS SYSTEM
      • Central Nervous System
    • NERVOUS SYSTEM DISORDERS
      • Alzheimer's Disease
      • Multiple Sclerosis
      • Parkinson's Disease
      • Stroke
    • BIOMARKER EXAMPLES
    • NEW DEVELOPMENTS
      • Table Selected Neurological Disease Markers in Development
    • TOTAL MARKET SIZE AND FORECAST
      • Table Global Nervous System Disorder Biomarker Market 2008-2018
      • Nervous System Disorder Biomarker Market by Geographical Region
    • COMPETITOR SUMMARY
  • Market Summary
    • MARKET CONSIDERATIONS
    • MARKET OVERVIEW
      • Table The Global Medical Biomarker Market 2008-2018
      • Medical Biomarkers Market by Application
      • Medical Biomarkers Market by Geographical Region
  • Company Profiles
    • INTRODUCTION
    • 20/20 GENESYSTEMS, INC.
      • Company Overview
    • ABBOTT LABORATORIES
      • Company Overview
    • AFFYMETRIX
      • Company Overview
    • AGENDIA, INC. USA
      • Company Overview
    • ALERE, INC
      • Company Overview
    • ASURAGEN, INC.
      • Company Overview
    • BECKMAN COULTER, INC
      • Company Overview
    • BECTON, DICKINSON
      • Company Summary
    • BIOCARTIS S.A.
      • Company Overview
    • BIODESIX, INC.
      • Company Overview
    • BIOMERIEUX SA
    • BIOREFERENCE LABORATORIES, INC
      • Company Overview
    • BIOTHERANOSTICS, INC.
      • Company Overview
    • CARDIODX, INC
      • Company Overview
    • CELERA ALAMEDA
    • CLARIENT, INC
      • Company Overview
    • DECODE GENETICS, INC.
      • Company Overview
    • DIAGENIC ASA
      • Company Overview
    • GENOMIC HEALTH, INC.
      • Company Overview
    • GENOPTIX MEDICAL LABORATORY
      • Company Overview
    • ILLUMINA, INC.
      • Company Overview
    • JOHNSON &JOHNSON
      • Company Overview
    • LIFE TECHNOLOGIES CORPORATION
      • Company Overview
    • MEMORY DX
      • Company Overview
    • MYRIAD GENETICS, INC.
      • Company Overview
    • NANOSTRING TECHNOLOGIES, INC.
      • Company Overview
    • OPKO HEALTH, INC.
      • Company Overview
    • PROVISTA DX
      • Company Overview
    • QIAGEN N.V.
      • Company Overview
    • ROCHE
      • Company Overview
    • SIEMENS HEALTHCARE
      • Company Overview
    • SINGULEX, INC
      • Company Overview
    • TETHYS BIOSCIENCE
      • Company Overview
    • THERMO FISHER SCIENTIFIC
      • Company Overview
  • List of Contributors

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report